Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axonics Inc (NQ: AXNX )

50.30 -1.31 (-2.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 307,252
Open 51.72
Bid (Size) 50.01 (1)
Ask (Size) 50.60 (1)
Prev. Close 51.61
Today's Range 50.04 - 51.98
52wk Range 46.57 - 79.92
Shares Outstanding 46,134,513
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
 
Via Benzinga
Where Axonics Stands With Analysts
 
Via Benzinga

Performance

YTD
-15.66%
-15.66%
1 Month
-12.05%
-12.05%
3 Month
-4.37%
-4.37%
6 Month
-21.93%
-21.93%
1 Year
-9.19%
-9.19%

More News

Read More
Axonics Q1 Soars Past Estimates: Analysts Say Annual Sales Outlook Is 'Conservative'
Via Benzinga
Analyst Ratings for Axonics
Via Benzinga
Axonics Reports First Quarter 2023 Financial Results
From Axonics, Inc.
Via Business Wire
Axonics Earnings Preview
Via Benzinga
Earnings Scheduled For March 1, 2023
Via Benzinga
Axonics Modulation Tech Earnings Preview
Via Benzinga
Analyst Ratings for Axonics
Via Benzinga
2 Fast-Growing Healthcare Stocks to Buy and Hold
Via The Motley Fool
Earnings Scheduled For May 1, 2023
Via Benzinga
Axonics to Participate in Upcoming Investor Conferences
From Axonics, Inc.
Via Business Wire
Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation
From Axonics, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023
Via Benzinga
Axonics to Report First Quarter 2023 Financial Results on May 1
From Axonics, Inc.
Via Business Wire
Axonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the Americas
From Axonics, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2023
Via Benzinga
Axonics to Participate in the SUFU 2023 Winter Meeting
From Axonics, Inc.
Via Business Wire
Axonics Reports Fourth Quarter and Fiscal Year 2022 Financial Results
From Axonics, Inc.
Via Business Wire
Axonics to Report Fourth Quarter 2022 Financial Results on March 1
From Axonics, Inc.
Via Business Wire
Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
From Axonics, Inc.
Via Business Wire
Why Axonics Shares Are Trading Higher Today?
Via Benzinga
Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue Guidance
From Axonics, Inc.
Via Business Wire
Axonics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Axonics, Inc.
Via Business Wire
Axonics Receives Health Canada Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
From Axonics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.